489 related articles for article (PubMed ID: 20433254)
1. Linezolid treatment of shunt-related cerebrospinal fluid infections in children.
Yilmaz A; Dalgic N; Müslüman M; Sancar M; Colak I; Aydin Y
J Neurosurg Pediatr; 2010 May; 5(5):443-8. PubMed ID: 20433254
[TBL] [Abstract][Full Text] [Related]
2. Experience with linezolid therapy in children with osteoarticular infections.
Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
[TBL] [Abstract][Full Text] [Related]
3. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
4. Linezolid in the treatment of Gram-positive prosthetic joint infections.
Bassetti M; Vitale F; Melica G; Righi E; Di Biagio A; Molfetta L; Pipino F; Cruciani M; Bassetti D
J Antimicrob Chemother; 2005 Mar; 55(3):387-90. PubMed ID: 15705640
[TBL] [Abstract][Full Text] [Related]
5. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
[TBL] [Abstract][Full Text] [Related]
6. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
7. Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection.
Cook AM; Ramsey CN; Martin CA; Pittman T
Pediatr Neurosurg; 2005; 41(2):102-4. PubMed ID: 15942282
[TBL] [Abstract][Full Text] [Related]
8. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T
Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
[TBL] [Abstract][Full Text] [Related]
9. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of linezolid in liver transplant patients.
Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
[TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of linezolid in children.
Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid penetration and bacteriostatic activity of linezolid against Enterococcus faecalis in a child with a ventriculoperitoneal shunt infection.
Milstone AM; Dick J; Carson B; Siberry GK
Pediatr Neurosurg; 2007; 43(5):406-9. PubMed ID: 17786008
[TBL] [Abstract][Full Text] [Related]
13. Linezolid in the treatment of implant-related chronic osteomyelitis.
Vercillo M; Patzakis MJ; Holtom P; Zalavras CG
Clin Orthop Relat Res; 2007 Aug; 461():40-3. PubMed ID: 17514011
[TBL] [Abstract][Full Text] [Related]
14. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis.
Boak LM; Li J; Spelman D; du Cros P; Nation RL; Rayner CR
Ann Pharmacother; 2006; 40(7-8):1451-5. PubMed ID: 16772405
[TBL] [Abstract][Full Text] [Related]
16. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
[TBL] [Abstract][Full Text] [Related]
17. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
McKinnon PS; Sorensen SV; Liu LZ; Itani KM
Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
[TBL] [Abstract][Full Text] [Related]
18. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.
Birmingham MC; Rayner CR; Meagher AK; Flavin SM; Batts DH; Schentag JJ
Clin Infect Dis; 2003 Jan; 36(2):159-68. PubMed ID: 12522747
[TBL] [Abstract][Full Text] [Related]
19. Linezolid for the treatment of multidrug-resistant tuberculosis.
Fortún J; Martín-Dávila P; Navas E; Pérez-Elías MJ; Cobo J; Tato M; De la Pedrosa EG; Gómez-Mampaso E; Moreno S
J Antimicrob Chemother; 2005 Jul; 56(1):180-5. PubMed ID: 15911549
[TBL] [Abstract][Full Text] [Related]
20. Linezolid for the treatment of complicated skin and skin structure infections in children.
Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
